NHS
-
healthNHS Prepares for Increased A&E Visits During World Cup
NHS warns fans to prioritize health amid expected rise in A&E visits following World Cup matches.
-
healthThe Hidden Crisis of Hypermobility: Lives Derailed by Undiagnosed hEDS
Undiagnosed hypermobile Ehlers-Danlos syndrome devastates lives, with urgent calls for better diagnosis and treatment.
-
healthEngland HPV Vaccine Program Achieves 100% Mortality Reduction in Young Women
Landmark Lancet study confirms England's HPV vaccination scheme eliminated cervical cancer deaths in women aged 20-24, preventing approximately 200 fatalities and validating WHO elimination goals.
-
healthPhilips and Disney Transform Pediatric MRI Scans with Immersive Experience
Royal Philips partners with Disney to reduce pediatric MRI anxiety, cutting stress by 43% and general anesthesia rates across NHS sites.
-
healthBritish Women Rank Among Europe's Angriest, Survey Finds
A global survey reveals rising anger among British women, linked to failures in healthcare.
-
worldEurope Rethinks Palantir: Privacy, Sovereignty Drive Shift from US Defense Tech
European governments seek alternatives to Palantir over privacy and sovereignty concerns, signaling a major shift in defense contracts and data partnerships.
-
healthNHS Greenlights Revolutionary Ovarian Cancer Drug After Two-Decade Hiatus
NHS approves AbbVie's targeted therapy mirvetuximab soravtansine for platinum resistant ovarian cancer, extending survival and marking the first new treatment in 20 years.
-
healthNHS Approves New ‘Trojan Horse’ Drug for Ovarian Cancer
NHS approves mirvetuximab soravtansine, a targeted therapy extending survival for hard-to-treat ovarian cancer patients.